Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.
| Data(s) |
2010
|
|---|---|
| Identificador |
https://serval.unil.ch/?id=serval:BIB_420F28766E70 isbn:1471-230X[electronic], 1471-230X[linking] pmid:20598161 doi:10.1186/1471-230X-10-71 isiid:000282773600002 |
| Idioma(s) |
en |
| Fonte |
BMC Gastroenterology, vol. 10, pp. 71 |
| Palavras-Chave | #Adult; Antiviral Agents/therapeutic use; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B/economics; Hepatitis B/immunology; Hepatitis B Antibodies/adverse effects; Hepatitis B Antibodies/economics; Humans; Immunoglobulins/economics; Immunoglobulins/therapeutic use; Liver Transplantation/immunology; Male; Middle Aged; Plasma; Recurrence/prevention & control; Treatment Outcome |
| Tipo |
info:eu-repo/semantics/article article |
